InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,168.00
(
0.52%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
81.99
(
-0.17%
)
Bitcoin
66,325.25
(
-0.47%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

gr8db8

Send PM Follow Ignore
Followers 0
Posts 484
Boards Moderated 0
Alias Born 10/10/2014

gr8db8

Re: zuize post# 55466

Friday, 10/24/2014 7:50:24 PM

Friday, October 24, 2014 7:50:24 PM

Post# of 80490
@zuize spot on ... especially the list of competitors. AP26113 has a long road ahead but current indications (from actual patients) are that it is very effective and has minimal side effects. The question they all want to learn is ... for how long? since they're all used to seeing/experiencing eventual resistance/mutations.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up